Cellerant Therapeutics, Inc.

Return to Grants

Total Awards:
Award Value:
Institution type:
For profit
Short Name:
Cellerant Therapeutics

Awards to the Institution

Program Type Investigator Grant Title Award Value
Late Stage Preclinical Projects Swapna Panuganti Development of CLT030-ADC, a Leukemic Stem Cell Targeting Antibody-Drug-Conjugate, for Treatment of Acute Myeloid Leukemia $6,863,755